210 related articles for article (PubMed ID: 24940805)
1. Ofloxacin resistance in Mycobacterium tuberculosis is associated with efflux pump activity independent of resistance pattern and genotype.
Sun Z; Xu Y; Sun Y; Liu Y; Zhang X; Huang H; Li C
Microb Drug Resist; 2014 Dec; 20(6):525-32. PubMed ID: 24940805
[TBL] [Abstract][Full Text] [Related]
2. Effect of efflux pump inhibitors on drug susceptibility of ofloxacin resistant Mycobacterium tuberculosis isolates.
Singh M; Jadaun GP; Ramdas ; Srivastava K; Chauhan V; Mishra R; Gupta K; Nair S; Chauhan DS; Sharma VD; Venkatesan K; Katoch VM
Indian J Med Res; 2011 May; 133(5):535-40. PubMed ID: 21623040
[TBL] [Abstract][Full Text] [Related]
3. Genotype analysis of ofloxacin-resistant multidrug-resistant
Gupta A; Sinha P; Rathod S; Shanmugam SK; Uma Devi KR; Anupurba S; Nema V
Indian J Med Res; 2020 Apr; 151(4):361-370. PubMed ID: 32461400
[TBL] [Abstract][Full Text] [Related]
4. Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs.
Gupta AK; Katoch VM; Chauhan DS; Sharma R; Singh M; Venkatesan K; Sharma VD
Microb Drug Resist; 2010 Mar; 16(1):21-8. PubMed ID: 20001742
[TBL] [Abstract][Full Text] [Related]
5. [Induction in vitro and stability of Mycobacterium tuberculosis resistance to ofloxacin].
Yang H; Hu Z; Sha W; Lu J; Cui Z; Wang J; Huang X; Xiao H
Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Apr; 48(4):318-23. PubMed ID: 24969458
[TBL] [Abstract][Full Text] [Related]
6. Efflux pump effects on
Valıyeva G; Durupınar B; Coban AY
J Chemother; 2023 Nov; 35(7):601-609. PubMed ID: 36718107
[TBL] [Abstract][Full Text] [Related]
7. Performance of Sequencing in Predicting Ofloxacin Resistance in
Wang Z; Xie T; Mu C; Sun R; Wang C; Zhao H; Ju H
Ann Clin Lab Sci; 2018 Jan; 48(1):69-74. PubMed ID: 29530999
[TBL] [Abstract][Full Text] [Related]
8. Assessment of trends of ofloxacin resistance in Mycobacterium tuberculosis.
Verma JS; Nair D; Rawat D; Manzoor N
Indian J Med Microbiol; 2011; 29(3):280-2. PubMed ID: 21860110
[TBL] [Abstract][Full Text] [Related]
9. High incidence of fluoroquinolone resistance and effect of efflux pump inhibitors on moxifloxacin resistance among Mycobacterium tuberculosis isolates causing urinary tract infection in Taiwan.
Chien JY; Yu CJ; Hsueh PR
Int J Antimicrob Agents; 2017 Sep; 50(3):491-495. PubMed ID: 28668684
[TBL] [Abstract][Full Text] [Related]
10. Pre-XDR & XDR in MDR and Ofloxacin and Kanamycin resistance in non-MDR Mycobacterium tuberculosis isolates.
Jain A; Dixit P; Prasad R
Tuberculosis (Edinb); 2012 Sep; 92(5):404-6. PubMed ID: 22789499
[TBL] [Abstract][Full Text] [Related]
11. Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Bakuła Z; Napiórkowska A; Kamiński M; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J; Jagielski T
J Microbiol Immunol Infect; 2016 Jun; 49(3):439-44. PubMed ID: 26117528
[TBL] [Abstract][Full Text] [Related]
12. Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through efflux.
Louw GE; Warren RM; Gey van Pittius NC; Leon R; Jimenez A; Hernandez-Pando R; McEvoy CR; Grobbelaar M; Murray M; van Helden PD; Victor TC
Am J Respir Crit Care Med; 2011 Jul; 184(2):269-76. PubMed ID: 21512166
[TBL] [Abstract][Full Text] [Related]
13. Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China.
Zhang Z; Pang Y; Wang Y; Liu C; Zhao Y
Int J Antimicrob Agents; 2014 Mar; 43(3):231-5. PubMed ID: 24439458
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of gyrA and B gene mutations in fluoroquinolone-resistant and -sensitive clinical isolates of Mycobacterium tuberculosis and their relationship with MIC of ofloxacin.
Singh P; Jain A; Dixit P; Prakash S; Jaiswal I; Venkatesh V; Singh M
J Antibiot (Tokyo); 2015 Jan; 68(1):63-6. PubMed ID: 25052485
[TBL] [Abstract][Full Text] [Related]
15. Correlating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assay.
Kambli P; Ajbani K; Sadani M; Nikam C; Shetty A; Udwadia Z; Rodwell TC; Catanzaro A; Rodrigues C
Tuberculosis (Edinb); 2015 Mar; 95(2):137-41. PubMed ID: 25522842
[TBL] [Abstract][Full Text] [Related]
16. A novel resistance mutation in eccC5 of the ESX-5 secretion system confers ofloxacin resistance in Mycobacterium tuberculosis.
Eilertson B; Maruri F; Blackman A; Guo Y; Herrera M; van der Heijden Y; Shyr Y; Sterling TR
J Antimicrob Chemother; 2016 Sep; 71(9):2419-27. PubMed ID: 27261264
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterisation of extensively drug-resistant Mycobacterium tuberculosis isolates in China.
Zhao LL; Sun Q; Zeng CY; Chen Y; Zhao B; Liu HC; Xia Q; Zhao XQ; Jiao WW; Li GL; Wan KL
Int J Antimicrob Agents; 2015 Feb; 45(2):137-43. PubMed ID: 25465521
[TBL] [Abstract][Full Text] [Related]
18. Stepwise decrease in moxifloxacin susceptibility amongst clinical isolates of multidrug-resistant Mycobacterium tuberculosis: correlation with ofloxacin susceptibility.
Kam KM; Yip CW; Cheung TL; Tang HS; Leung OC; Chan MY
Microb Drug Resist; 2006; 12(1):7-11. PubMed ID: 16584301
[TBL] [Abstract][Full Text] [Related]
19. [The effects of gene mutation related to drug resistance and drug efflux pump in extensively drug-resistant tuberculosis clinical isolates].
Cui ZL; Wang XL; Wang J; Lu JM; Hu ZY
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jul; 33(7):505-9. PubMed ID: 20979796
[TBL] [Abstract][Full Text] [Related]
20. Expression analysis of 10 efflux pump genes in multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis clinical isolates.
Kardan-Yamchi J; Kazemian H; Haeili M; Harati AA; Amini S; Feizabadi MM
J Glob Antimicrob Resist; 2019 Jun; 17():201-208. PubMed ID: 30654147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]